Financials
- Market Capitalization 263.98 M
- Employee 152
- Founded 2016
- CEO N/A
- Website www.entradatx.com
- Headquarter Delaware, United States
- FIGI BBG00MTSMC16
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.15
Fiyat/satışlar oranı
91.18
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3414 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.07 USD | +0.49% | -0.48% | +23.95% | +15.00% | 273.31 M USD | ||
| 3419 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.96 USD | -2.00% | -17.30% | +23.27% | +317.02% | 263.74 M USD | ||
| 3440 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.29 USD | -5.19% | -4.08% | -6.53% | -33.94% | 262.03 M USD | ||
| 3459 | SRZN Surrozen, Inc. - Common Stock | 21.88 USD | 0.00% | -4.87% | -5.65% | +162.98% | 254.03 M USD |